Anti-thyroglobulin antibody

Anti-thyroglobulin antibody (ATG), English name anti-thyroglobulin antibodies, was discovered by Roitt et al. In 1958 during serological research on autoimmune thyroiditis (Hashimoto's thyroiditis, etc.). ATG's target antigen, thyroglobulin (TG), is a soluble iodinated glycoprotein synthesized and secreted by thyroid epithelial cells. It has a molecular weight of 660 kD and consists of 2748 amino acids. It is a biosynthetic precursor of T3 (triiodothyronine) and T4 (tet-raiodothyronine, thyroxine, thyroxine). It is mainly stored in colloidal form in thyroid filters. In the vacuole cavity, the content of normal human serum is extremely small (10-40 ng / ml). Witebsky et al. Immunized rabbits with the same type of thyroid tissue and induced ATG and rabbit thyroiditis similar to human Hashimoto's thyroiditis. ATG is the most typical organ-specific antibody of various autoantibodies in humans. It is mainly IgG, with IgA accounting for 20% and IgM accounting for 5%. Among the four subclasses of IgG with ATG activity, the proportion of IgG increased significantly, about 6 times its normal proportion (5%). ATG cannot bind complement, which may have something to do with the higher proportion of IgG 4 subclasses. It may be more important because the epitopes on thyroglobulin are far apart, and cross-linking cannot be formed between the antibody molecules that it binds The reason.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.